Posts by SharpBrains
Brain imaging AI start-up Neurophet raises $15M to better direct Alzheimer’s treatments, lower ARIA side-effects
Korean AI startups Allganize, Neurophet raise over $35 mn (The Korea Economic Daily): Founded in 2016, the company plans to next year roll out its new AI analysis program that can detect side effects of Alzheimer’s disease treatments with a microhemorrhage diagnosis.
Read MoreOn neuroplasticity, cognition, aging, medication, Alzheimer’s, board games, brain teasers, and more
Welcome to a new edition of SharpBrains e‑newsletter, featuring fascinating research findings on neuroplasticity, cognition, aging, medication, Alzheimer’s, board games, and more, plus some brain teasers to get you in great shape for Halloween. #1. Study: Playing board games like Chess, Mahjong, Go, helps slow cognitive decline as we age (but with clear differences in…
Read MoreStudy: Playing board games like Chess, Mahjong, Go, helps slow cognitive decline as we age (but with clear differences in neurobiology and improved function)
Playing Board Games May Slow Cognitive Decline, Improve QoL (Medscape): Playing chess or other board games slows cognitive decline and improves quality of life in older patients, results of a new systematic review suggest. … After searching the published literature, Pozzi and his colleagues selected 15 studies for the review. The studies assessed the impact…
Read MoreBeyond the clinic: Can digital therapeutics (DTx) help boost mental health in the workforce at scale?
Hoping to Avoid Pear’s Fate, Behavioral Health-Focused DTx Companies Look to Employer Market (Behavioral Health Business): The digital therapeutics (DTx) industry is at a crossroads after one of the most prominent companies in the space, Pear Therapeutics, filed for bankruptcy earlier this year. The turmoil comes after DTx began catching on in the behavioral health…
Read MoreFour reasons to question “new generation” monoclonal antibody Alzheimer’s drugs such as aducanumab (Aduhelm), lecanemab (Leqembi), donanemab
New Alzheimer’s Drugs Don’t Deserve the Hype (Being Patient): A prominent childhood memory is of my grandparents living with and then dying from dementia. As is universal with dementia, there was a double blow: watching my grandparents lose their identity and seeing the suffering of those closest to them.
Read More“To do nothing is not an option”: The NHS Confederation releases digital mental health whitepaper
The NHS Confederation–the membership organisation for healthcare providers in England, Wales and Northern Ireland– has just released a quite comprehensite 45-page whitepaper titled Maximising the potential of digital in mental health. Some of the highlights: To do nothing is not an option. If we don’t make more progress we miss a key opportunity to make…
Read More